• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON & CO. (SPARKS) BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON & CO. (SPARKS) BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Model Number 221788
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/17/2023
Event Type  malfunction  
Manufacturer Narrative
H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that while using bd bbl¿ thioglycollate medium, enriched with vitamin k1 and hemin, there was contamination of 17 tubes.No patient impact reported.The following information was provided by the initial reporter: "customer reports contamination of #221788 lot number 3019808.".
 
Event Description
It was reported that while using bd bbl¿ thioglycollate medium, enriched with vitamin k1 and hemin, there was contamination of 17 tubes.No patient impact reported.The following information was provided by the initial reporter: "customer reports contamination of #221788 lot number 3019808.".
 
Manufacturer Narrative
H.6.Investigation summary: material 221788 is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued, and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.The batch history record (bhr) review for batch 3019808 was satisfactory per internal procedures.Formulation, filling, torquing, and autoclaving processes were within specifications.In process checks were performed during manufacturing at designated intervals per procedures.Qc inspection and testing were satisfactory at time of release.The complaint history was reviewed, and one other complaint has been taken on this batch.Retention samples from batch 3019808 (10 tubes) were available for inspection.No media defects were observed in 10/10 retention samples.No signs of turbidity were observed in 10/10 retention tubes.For further investigation, two uninoculated tubes were incubated.One tube was incubated at 33-37- degree celsius and one tube was incubated in at 20-25-degree celsius.At the seventh day of incubation there were no signs of microbial growth or change in the media overall appearance.Eleven photos were received to assist with the investigation: two photos show the label of a partial bd-100 pack carton from batch 3019808 (carton number 0414).Two photos show a partial tube (the cap cannot be seen).The focus was on the media.The media appears yellow with particles/hazy.Seven photos show partial tubes from batch 3019808.The media in the tubes shows yellow media with particles/hazy appearance.Returns were received to assist with the investigation.A 100-pack bd original carton from batch 3019808 (carton number 0401) was received with tapped sides.All 100/100 tubes received were from batch 3019808.The broth appearance of all 100/100 returned tubes was medium yellow with particles/hazy appearance.All 100/100 returned tubes were incubated at 33-37-degrees celsius.At seven-days of incubation there was no change in the media appearance the media still appeared hazy with particles.Two returned tubes were boiled as stated in the ifu, and the media cleared to a medium yellow as described in the certificate of analysis.The following fields were updated due to additional information: d9: device available for evaluation:  yes.D9: returned to manufacturer on: 21-july-2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17375227
MDR Text Key319709310
Report Number1119779-2023-00795
Device Sequence Number1
Product Code JSG
UDI-Device Identifier30382902217887
UDI-Public30382902217887
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K803023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/20/2024
Device Model Number221788
Device Catalogue Number221788
Device Lot Number3019808
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/17/2023
Initial Date FDA Received07/21/2023
Supplement Dates Manufacturer Received10/19/2023
Supplement Dates FDA Received11/01/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/19/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-